MFG
ANVS icon

Merit Financial Group’s Annovis Bio ANVS Stock Holding History

Merit Financial Group’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-81,316
Closed -$181K – 2365
2026
Q1 		$181K Hold
81,316
– – ﹤0.01% 1951
2025
Q4 		$281K Hold
81,316
– – ﹤0.01% 1599
2025
Q3 		$168K Sell
81,316
-10,000
-11% -$25K ﹤0.01% 1699
2025
Q2 		$198K Sell
91,316
-6,500
-7% -$12.8K ﹤0.01% 1570
2025
Q1 		$147K Sell
97,816
-700
-0.7% -$2.14K ﹤0.01% 1335
2024
Q4 		$496K Buy
98,516
+71,816
+269% +$520K 0.01% 731
2024
Q3 		$215K Buy
26,700
+5,000
+23% +$46.8K ﹤0.01% 768
2024
Q2 		$125K Sell
21,700
-500
-2% -$4.05K ﹤0.01% 885
2024
Q1 		$115K Hold
22,200
– – ﹤0.01% 839
2023
Q4 		$415K Sell
22,200
-19,000
-46% -$168K 0.01% 533
2023
Q3 		$391K Sell
41,200
-1,200
-3% -$14.8K 0.01% 513
2023
Q2 		$606K Sell
42,400
-500
-1% -$7.07K 0.02% 423
2023
Q1 		$661K Sell
42,900
-250
-0.6% -$4.04K 0.02% 350
2022
Q4 		$580K Buy
43,150
+23,150
+116% +$289K 0.02% 392
2022
Q3 		$274K Buy
+20,000
New +$263K 0.01% 460

Other funds holding ANVS

EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Merit Financial Group's ANVS Position: Q2 2026 in Review

Merit Financial Group sold out of Annovis Bio (ANVS) in Q2 2026, closing a stake of 81,316 shares — an estimated $181K sold.

Merit Financial Group first reported a position in ANVS in Q3 2022 and held it in 15 quarters. The position peaked at $661K in Q1 2023. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • Merit Financial Group reported no remaining Annovis Bio position as of Q2 2026 after selling out during the quarter.
  • Merit Financial Group sold 81,316 Annovis Bio shares in Q2 2026, an estimated $181K.
  • Merit Financial Group first reported a position in Annovis Bio in Q3 2022 and held it in 15 quarters.
  • Merit Financial Group's Annovis Bio position peaked at $661K in Q1 2023.
  • 61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.